share_log

Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating

Alliance Global Partners Initiates Coverage On Chromocell Therapeutics With Buy Rating

全球合作伙伴開始對Chromocell Therapeutics進行買入評級覆蓋
Benzinga ·  06/18 13:28

Alliance Global Partners analyst James Molloy initiates coverage on Chromocell Therapeutics (AMEX:CHRO) with a Buy rating.

Alliance Global Partners的分析師James Molloy爲Chromocell Therapeutics (美交所:CHRO) 提供買入評級的股票覆蓋報告。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論